Suven Pharmaceuticals Ltd
NSE:SUVENPHAR

Watchlist Manager
Suven Pharmaceuticals Ltd Logo
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Watchlist
Price: 1 287.15 INR -0.52%
Market Cap: 327.7B INR
Have any thoughts about
Suven Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

SUVENPHAR Price Targets Summary
Suven Pharmaceuticals Ltd

Wall Street analysts forecast SUVENPHAR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SUVENPHAR is 1 356.6 INR with a low forecast of 1 343.3 INR and a high forecast of 1 396.5 INR.

Lowest
Price Target
1 343.3 INR
4% Upside
Average
Price Target
1 356.6 INR
5% Upside
Highest
Price Target
1 396.5 INR
8% Upside
Suven Pharmaceuticals Ltd Competitors:
Price Targets
4016
Middle East Pharmaceutical Industries Company SJSC
10% Upside
ENZY
Enzymatica AB (publ)
124% Upside
600566
Hubei Jumpcan Pharmaceutical Co Ltd
85% Upside
NKTR
Nektar Therapeutics
291% Upside
SECARE
Swedencare AB (publ)
30% Upside
002001
Zhejiang Nhu Co Ltd
23% Upside
PBH
Prestige Consumer Healthcare Inc
8% Upside
ELAN
Elanco Animal Health Inc
45% Upside

Revenue
Forecast

Revenue Estimate
Suven Pharmaceuticals Ltd

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's revenue is 6%. The projected CAGR for the next 3 years is 18%.

6%
Past Growth
18%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Suven Pharmaceuticals Ltd

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's operating income is 0%. The projected CAGR for the next 2 years is 34%.

0%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Net Income
Forecast

Net Income Estimate
Suven Pharmaceuticals Ltd

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's net income is -1%. The projected CAGR for the next 3 years is 29%.

-1%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SUVENPHAR's stock price target?
Price Target
1 356.6 INR

According to Wall Street analysts, the average 1-year price target for SUVENPHAR is 1 356.6 INR with a low forecast of 1 343.3 INR and a high forecast of 1 396.5 INR.

What is Suven Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
18%

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's revenue is 6%. The projected CAGR for the next 3 years is 18%.

What is Suven Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
34%

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's operating income is 0%. The projected CAGR for the next 2 years is 34%.

What is Suven Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
29%

For the last 4 years the compound annual growth rate for Suven Pharmaceuticals Ltd's net income is -1%. The projected CAGR for the next 3 years is 29%.

Back to Top